Filtricine Appoints a New Chief Executive Officer - Filtricine Latest NewsFiltricine Preclinical Results PublishedDecember 22, 2021Filtricine is pleased to announce that the preclinical research results of its proprietary medical food technologyRead more Clinical Results Presented at PCF RetreatNovember 6, 2021Filtricine is pleased to announce that researchers leading a Filtricine-sponsored prostate cancer clinical study at Stanford UniversityRead more We Are Excited to Announce Filtricine's Latest Round of InvestmentAugust 3, 2021Filtricine's Seed Round announcement, led by Boutique Venture Partners and Berkeley Catalyst FundRead more Filtricine Initiates the First Clinical StudyJuly 8, 2020Filtricine today announced the start of its first human clinical study among prostate cancer patients.Read more Filtricine Presents Research at Scientific Conference for Cancer TreatmentNovember 1, 2019At the AACR-NCI-EORTC conference for molecular targets (#Targets19) in BostonRead more IndieBio Demo Day PresentationNovember 6, 2018We proudly graduated from the phenomenal four-month program at IndieBio.Read more View all